CTNND1 and cancer: In EMT, ESRP1 was thought to directly regulate these subtypes such as FGFR2, ENAH, CD44 and CTNND, thereby losing cell-to-cell adhesion and polarity, increasing cancer cell invasion and migration [2–4].